Alaxo GMBH
This article was originally published in Start Up
Executive Summary
Earlier this decade, a German citizen suffering from obstructive sleep apnea (OSA) came up with the idea of mechanically splinting the airways in the throat to ensure free flow of air into the lungs, rather than relying on traditional pressure-based splinting of the airways, as with continuous positive airway pressure therapy (CPAP). That concept became the AlaxoStent from Alaxo GMBH, a self-expandable, shape-memory metal braid that the patient can insert into his nose and throat at night and remove in the morning.
You may also be interested in...
Sleep Apnea Devices: The Changing Of The Guard
The current specialty-dominated care paradigm for sleep apnea can't scale-up to meet the demands of an enormous and serious chronic disease. New companies help move diagnosis and treatment to the physicians that see patients first.
Start-Up Previews (04/2009)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "New Stem Cell Therapies," features profiles of Amorcyte, California Stem Cell, Cardio3 BioSciences, CellDesign and Fate Therapeutics. Plus these Start-Ups Across Health Care: Alaxo, CorNova, PCI Biotech.
Start-Up Previews (04/2009)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "New Stem Cell Therapies," features profiles of Amorcyte, California Stem Cell, Cardio3 BioSciences, CellDesign and Fate Therapeutics. Plus these Start-Ups Across Health Care: Alaxo, CorNova, PCI Biotech.